Altman R D, Brown M, Gargano F
Clin Orthop Relat Res. 1987 Apr(217):152-61.
Clinical and laboratory evaluation with bone scan, radiography, and computed tomography were performed on 25 patients with severe Paget's disease of bone and low back pain. Back pain was classified as caused by Paget's disease in only three patients. The remaining 22 patients had coexistent Paget's disease and osteoarthritis. There was difficulty separating the cause of back pain in those patients with coexistent Paget's disease and osteoarthritis, even when the diseases were present at different levels of the spine. The pathogenesis of Paget's disease appears to precipitate osteoarthritis and several low back syndromes. Suppressive therapy with disodium etidronate (EHDP) for Paget's disease was of benefit in eight of 22 patients (36%) with identifiable osteoarthritis. It is suggested that EHDP and perhaps other suppressive agents for Paget's disease receive limited use in patients with back pain unless a defined pagetic lesion appears related to the clinical syndrome in the absence of identifiable osteoarthritis.
对25例患有严重骨Paget病并伴有腰痛的患者进行了骨扫描、X线摄影和计算机断层扫描的临床及实验室评估。仅3例患者的背痛被归类为由Paget病引起。其余22例患者同时患有Paget病和骨关节炎。即使这些疾病存在于脊柱的不同节段,在同时患有Paget病和骨关节炎的患者中,区分背痛的病因也存在困难。Paget病的发病机制似乎会促使骨关节炎和几种腰痛综合征的发生。对于22例患有可识别骨关节炎的患者,使用依替膦酸二钠(EHDP)对Paget病进行抑制治疗,其中8例(36%)患者受益。建议除非在没有可识别骨关节炎的情况下,明确的Paget病病变似乎与临床综合征相关,否则EHDP以及可能的其他用于治疗Paget病的抑制药物在背痛患者中的使用应受到限制。